Home › NDC Lookup › RxCUI directory › RxCUI 1726416

Carboxymethylcellulose sodium 0.01 MG/MG / glycerin 0.009 MG/MG Ophthalmic Gel — RxCUI 1726416

RxNorm drug concept · Semantic clinical drug
RxCUI 1726416 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1726416
Official nameCarboxymethylcellulose sodium 0.01 MG/MG / glycerin 0.009 MG/MG Ophthalmic Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascarboxymethylcellulose sodium 1 % / glycerin 0.9 % Ophthalmic Gel
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,916 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Carboxymethylcellulose sodium 0.01 MG/MG / glyce... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carboxymethylcellulose sodium 0.01 MG/MG / glycerin 0.009 MG/MG Ophthalmic Gel RxCUI 1726416

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Carboxymethylcellulose 2062
    • Glycerin 4910
    • Carboxymethylcellulose / glycerin 725123
    • Carboxymethylcellulose sodium 491498
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carboxymethylcellulose / glycerin Ophthalmic Gel 1374725
    • Carboxymethylcellulose sodium / glycerin Ophthalmic Gel 2649370
    • Carboxymethylcellulose / glycerin Ophthalmic Product 1151382
    • Carboxymethylcellulose sodium / glycerin Ophthalmic Product 2661825
    • Ophthalmic Gel 316963
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Carboxymethylcellulose sodium 0.01 MG/MG 1374724
    • Glycerin 0.009 MG/MG 1726415

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carboxymethylcellulose sodium 0.01 MG/MG SCDC · 1374724
  • Glycerin 0.009 MG/MG SCDC · 1726415
  • Carboxymethylcellulose / glycerin Ophthalmic Gel SCDF · 1374725
  • Carboxymethylcellulose sodium / glycerin Ophthalmic Gel SCDFP · 2649370
  • Carboxymethylcellulose / glycerin Ophthalmic Product SCDG · 1151382
  • Carboxymethylcellulose sodium / glycerin Ophthalmic Product SCDGP · 2661825

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1726416 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00023-5459-02 1 BOTTLE, DROPPER in 1 CARTON (0023-5459-02) / 2 mL in 1 BO... REFRESH OPTIVE Drops Allergan, Inc. 2015-09-30
00023-5459-10 1 BOTTLE, DROPPER in 1 CARTON (0023-5459-10) / 10 mL in 1 B... REFRESH OPTIVE Drops Allergan, Inc. 2015-09-30
Observed labelers: Allergan, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.1563
Range $1.1563–$1.1563 · middle 50% $1.1563–$1.1563 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.